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Summary 
 
The role of preS domains of the hepatitis B virus (HBV) envelope proteins in the 
first steps of viral infection has been restricted to their implication in virus 
attachment to a putative hepatocyte receptor. In order to explore a fusion activity 
in these regions, we used recombinant preS domains of two subtypes, adw and 
ayw, to characterize their interaction with liposomes. Binding experiments carried 
out with NBD-labeled proteins indicated that preS were able to interact in a 
monomeric way with acidic phospholipids vesicles, being the partition coefficient 
similar to that described for peptides which can insert deeply into bilayers. 
Fluorescence depolarization of DPH-labeled vesicles confirmed the specificity for 
negative charged phospholipids. Upon interaction the proteins induced 
aggregation, lipid mixing and release of internal contents of acidic vesicles at both 
acid and neutral pH in a concentration-dependent manner. The insertion of the 
preS domains into the hydrophobic core of the bilayer resulted in a protein 
conformational change which increased the helical content. Therefore all these 
results suggest that, besides their participation in the recognition of a cellular 
receptor, the preS domains could be involved in the fusion mechanism of HBV 
with the plasma membrane of target cells.  
 3
1. Introduction 
 
Hepatitis B virus (HBV) is a small enveloped DNA virus that belongs to the 
hepadnaviridiae family. It causes persistent infection of hepatocytes, resulting in 
some cases in the development of chronic hepatitis and hepatocellular carcinoma. 
Despite representing a worldwide health problem, the mechanisms of attachment 
and entry of HBV into target cells are still poorly understood, mainly caused by 
the lack of appropriated in vitro infection systems. In this regard, human primary 
hepatocyte cultures, which can be infected by the virus, have been described for 
their use in the study of the entry process of HBV [1], but these cells resulted very 
limited in supply and heterogeneous in quality and susceptibility to HBV [2]. The 
newly established HepaRG cells, a hepatoma cell line that has been shown to 
become susceptible to HBV infection upon treatment with DMSO and 
hydrocortisone [2, 3] could overcome these limitations although this kind of 
treatments might induce unnatural mechanisms of viral entry. 
The envelope proteins of HBV are assumed to have key roles in the binding 
and fusion of target cells. The virus possesses three surface proteins known as 
small (S), medium (M) and large (L) that are translated from a single open reading 
frame at three different translational start codons. Thus, all three proteins share 
226 amino acids (the complete S protein) at the carboxy-terminus; the M protein 
possesses an extension of 55 amino acids, termed as preS2 region, at the N-
terminus of S protein, while the L protein is composed of de entire M protein 
prolonged at the N-terminus by the preS1 region, which consists of 108 or 119 
residues depending on the HBV subtype. The preS1 and preS2 regions, known 
together as preS domains, have been implicated in the binding of the virus to 
hepatocytes [4, 5]. Several receptors for HBV have been proposed to interact with 
different regions of preS domains [6, 7] although none of them have been proven 
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to function in viral entry. Nowadays a generally accepted view is the involvement 
of preS1 in attachment to hepatocytes, being the viral entry activity of this region 
solely dependent on the integrity of its first 75 amino acids [8]. Moreover, recent 
studies suggested that lipoprotein lipase (LPL) may play a role in the initiation of 
HBV infection via interaction with the N-terminal part of preS1 [9]. 
 Regarding the role of HBV envelope proteins in the fusion step, a putative 
fusion peptide sequence of 16 amino acids at the N-terminus of S protein has been 
described [10]. A synthetic peptide comprising this predicted fusion region was 
shown to interact with model membranes, promoting liposome destabilization in a 
pH-dependent manner [11], and adopting an extended conformation during the 
process [12]. Evidence for the role of the N-terminal S peptide in fusion has been 
obtained after treatment of HBV virions with V8 protease, an enzyme that cleaves 
the S sequence at position 2, removing the preS domains and exposing the 
hydrophobic fusion peptide; intact HBV hardly infected HepG2 cells, but V8 
protease-digested HBV particles efficiently infected and proliferated in these 
human hepatoblastoma cell lines [13]. The destabilization properties observed for 
the HBV fusion peptide can be extended to other members of the hepadnavirus 
family, as demonstrated using oligopeptides corresponding to the N-terminal 
portion of duck and woodchuck hepatitis B viruses (DHBV and WHV, 
respectively) [14]. Likewise, V8 protease-digested WHV particles induced 
infectivity towards human HepG2 cells [15], confirming that the exposure of this 
consensus fusion motif is important in hepadnavirus entry.  
 Despite their location at the surface of natural virions, the preS domains 
have never been directly involved in the fusion process, being their role in viral 
entry only associated with the attachment of HBV particles to possible cellular 
receptors. With the aim to explore the fusogenic capabilities of these regions, two 
recombinant preS domains from adw and ayw subtypes, produced in E. Coli cells 
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as previously described [16] were used in membrane interaction studies. In this 
paper we describe that preS domains are able to interact with acidic phospholipid 
vesicles and to destabilize these membrane model systems, and hence, could 
contribute, together with the N-terminal S peptide, to the fusion of viral and 
cellular membranes. 
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 2. Materials and methods 
 
2.1. Reagents 
 
N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-dimyristoylphosphatidylethanolamine 
(NBD-PE), N-(lissamine rhodamine B sulfonyl)-diacylphosphatidylethanolamine 
(Rh-PE), egg phosphatidylglycerol (PG), and dimyristoylphosphatidylglycerol 
(DMPG) were provided by Avanti Polar Lipids. 8-Aminonaphtalene-1,3,6-
trisulfonic acid (ANTS), p-xylenebis(pyridinium) bromide (DPX) and 1,6-
diphenyl-1,3,5-hexatriene (DPH) and 4-fluoro-7-nitrobenz-2-oxa-1,3-diazole 
(NBD-F) were purchased from Molecular Probes. Triton X-100 was purchased 
from Boehringer Mannheim. All other reagents were obtained from Merck and 
Sigma. All solvents were of HPLC grade. 
 
2.2 Cloning, expression, purification and labeling of preS domains 
 
 The cDNAs coding for preS domains of subtypes adw and ayw were cloned 
as described previously in expression vectors that add six-histidine sequences at 
the carboxy-terminal end of each protein [16]. Escherichia coli strains BL21 
(DE3) and HMS174 (DE3) were transformed with the recombinant plasmids pT7-
7-preS-his-adw and pET-3d-preS-his-ayw respectively and isopropyl-D-
thiogalactopiranosyde (IPTG) was added to a final concentration of 0.5 mM to 
induce protein expression. Both recombinant proteins were purified using a single 
affinity-chromatography step in Sepharose CL-6B Ni-nitrilotriacetic acid (NTA) 
column (Qiagen), following procedures previously described, giving rise to highly 
pure and stable 20-25 mg of preS-his-ayw and 35-40 mg of preS-his-adw from 1L 
of culture media [16]. 
 7
 Fluorescent labeling of the N-terminus of the proteins was achieved 
following the procedure described by Rapaport and Shai [17]. Briefly, preS 
proteins were incubated at pH 6.8 with a ten molar excess of NBD-F for 4 h at 
room temperature. Unbound NBD-F was removed by means of a PD-10 column. 
The labeling of the protein could be monitored by the appearance of a maximum 
at 467 in the absorbance spectrum. 
 
2.3. Vesicle preparation 
 
 In all cases a lipid film was obtained by drying a chloroform:methanol (2:1) 
solution of the lipid under a current of nitrogen and this film was further kept 
under vacuum for 4-5 hours to completely remove the organic solvent. The 
phospholipids were resuspended at a concentration of 1 mg/ml in medium buffer 
(100 mM NaCl, 5 mM MES, 5 mM sodium citrate, 5 mM Tris, 1 mM EDTA) at 
the appropriate pH value and incubated for 1 hour at 37 ºC and eventually 
vigorously vortexed. This suspension was sonicated in a bath sonicator (Branson 
1200) and was subsequently subjected to nineteen cycles of extrusion in a Liposo 
Fast-Basic extruder apparatus (Avestin, Inc.) with 100-nm polycarbonate filters 
(Costar). When encapsulation was required, an additional step of five freeze-
thawing cycles was included after the sonication process. 
 
2.4. Binding experiments 
 
 Binding experiments were conducted as previously described [17]. In order 
to determine the degree of NBD-preS-his association with phospholipid vesicles, 
PC or PG vesicles were added to a fixed amount of labeled protein (0.15 μM) in 
medium buffer at the desired pH and incubated at 37 °C. The fluorescence 
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intensity at different lipid/protein molar ratios was registered in a SLM AMINCO 
8000C spectrofluorimeter (SLM Instruments), with excitation and emission 
wavelengths set at 468 and 530 nm, respectively. In all cases, fluorescence from 
control vesicles in the absence of labeled protein was subtracted. In order to 
obtain the partition coefficient, data were analyzed using the equation [17, 18]: 
Xb = Kp • Cf
where Xb is the molar ratio of bound protein per total lipid, Kp corresponds to the 
partition coefficient and Cf represents the equilibrium concentration of free 
protein in solution. It was assumed that proteins only partitioned over the outer 
leaflet of vesicles. Therefore, Xb values were corrected as Xb*= Xb/0.6 and the 
data analyzed as: 
Xb* = Kp* • Cf
Values of the corrected partition coefficient, Kp*, were determined from the initial 
slopes of the binding isotherms. 
 In order to calculate Xb, we estimated F∞, the fluorescence signal obtained 
with a saturating phospholipid concentration by extrapolating from a double 
reciprocal plot of F (total protein fluorescence) versus CL (total lipid 
concentration). At every phospholipid concentration, the fraction of bound protein 
can be calculated by the formula: 
fb = (F-F0)/( F∞-F0) 
where F0 represents the fluorescence of unbound protein and F∞ the fluorescence 
of bound protein. 
 
2.5. Fluorescence polarization  
 
 Fluorescence polarization measurements of the probe 1,6-diphenyl-1,3,5-
hexatriene (DPH) were taken in the SLM AMINCO 8000C spectrofluorimeter by 
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using 10 mm Glan-Thompson polarizers. DMPG and DMPC vesicles (0.14 mM) 
were prepared as indicated above containing DPH at a weight ratio of 1:500. The 
protein-vesicle mixtures were incubated for 30 min at 37 ºC and then cooled. The 
excitation was set at 365 nm and emission was measured at 425 nm, after 
equilibration of the samples at the indicated temperature. The temperature in the 
cuvette was maintained with a circulating water bath. 
 
2.6. Vesicle aggregation 
 
The increase in the optical density at 360 nm ( OD360) produced by addition 
of preS proteins to a phospholipid vesicle suspension, in medium buffer at the 
appropriated pH, was measured on a Beckman DU-7 spectrophotometer after 
incubation for 1 hour at 37 ºC. Values of control samples containing only vesicles 
and only protein were subtracted at each protein concentration. The final 
phospholipid concentration was kept at 0.14 mM. 
 
2.7. Release of aqueous contents 
 
Leakage was determined by the ANTS/DPX assay [19], which is based on 
the dequenching of ANTS fluorescence caused by its dilution upon release of the 
aqueous contents of one vesicle preparation containing both ANTS and DPX. It 
was performed by coencapsulating 12.5 mM ANTS and 45 mM DPX in 10 mM 
Tris, 20 mM NaCl, pH 7.2, in phospholipid vesicles. The lipid film was hydrated 
as described previously and the vesicles were sonicated 30 min. Afterwards the 
vesicles were subjected to five cycles of freeze-thawing in liquid nitrogen an 
passed 15 times through a Liposo Fast-Basic extruder apparatus (Avestin, Inc.) 
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with 100-nm polycarbonate filters (Costar). After the vesicles with the 
coencapsulated probe and quencher were formed, the whole sample was passed 
through a Sephadex G-75 column (Pharmacia) to separate the vesicles from the 
non encapsulated material using medium buffer for elution. Assays were 
performed in medium buffer at the appropriated pH, at a phospholipid 
concentration of 0.1-0.14 mM in medium buffer at the appropriated pH by 
incubating with different amounts of proteins for 1 h at 37 ºC and measuring in 
the SLM Aminco 8000C spectrofluorimeter. The excitation wavelength was set at 
385 nm and the ANTS emission was monitored at 520 nm. Both the excitation 
and emission slits were set at 4 mm. The excitation and emission polarizers were 
kept constant at 90º and 0º, respectively, to minimize interference due to 
dispersion. The fluorescence scale was set to 100 % by addition of 0.5 % Triton 
X-100, and 0% leakage was obtained measuring the fluorescence of control 
vesicles without protein. 
 
2.8. Lipid mixing assay 
 
Lipid mixing was monitored by using the classical fluorescent probe 
dilution assay [20], in which the decrease in the efficiency of the fluorescence 
energy transfer between NBD-PE (energy donor) and Rh-PE (energy acceptor) 
incorporated into liposomes, as a consequence of lipid mixing, is measured. 
Liposomes, in medium buffer at the appropriated pH, labeled with 1 mol% NBD-
PE and 1 mol% Rh-PE were mixed with unlabeled liposomes in a 1:9 molar ratio. 
After incubation of liposomes with the preS domains at different concentrations 
for 1 h at 37 ºC, emission spectra were recorded with the excitation wavelength 
set at 450 nm. Both the excitation and emission slits were set at 4 mm. The 
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excitation polarizer was kept constant at 90º and the emission polarizer was kept 
constant at 0º to minimize dispersive interference. The efficiency of the energy 
transfer was calculated from the ratio of the emission intensities at 530 and 590 
nm and the appropriated calibration curve. The final phospholipid concentration 
was 0.14 mM. The organic solvent itself had no effect on the efficiency of the 
energy transfer. 
 
2.9. Electron microscopy 
 
Samples of egg PG vesicles (obtained by extrusion through a 0.1 mm pore 
diameter polycarbonate filter) were incubated with preS proteins at different lipid 
and protein concentrations for 1 h at 37 ºC. Subsequently, the lipid-protein 
mixtures were applied to a glow-discharged 400-mesh Formvar-carbon-coated 
grid for 2 min. Grids were washed with deionized water and with PBS, and excess 
fluid was drawn away with filter paper. Samples were then negatively stained for 
5 min with 2% phosphotungstic acid at pH 7.0 and examined under a Zeiss EM 
902 (Jena, Germany) transmission electron microscope operating at 80 kV.  
 
2.10. Circular Dichroism 
 
 CD measurements were carried out on a Jasco spectropolarimeter, model 
J-715. All the measurements were carried out at 25 ºC with cells thermostated 
with a Neslab RTE-111 water bath. The spectra were taken in medium buffer at 
the desired pH and at a protein concentration of 0.10 mg/ml. The pathlength was 1 
mm. Five scans were averaged for each measurement and the contribution of the 
buffer was always subtracted. The spectra were calculated by using 110 as the 
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mean residue molecular mass and the results are expressed in terms of residue 
molar ellipticity in deg⋅cm2⋅dmol-1. The secondary structure of the protein was 
evaluated by computer fit of the dichroism spectra according to Convex 
Constraint Analysis (CCA) [21]. This method relies on an algorithm that 
calculates the contribution of the secondary structure elements that give rise to the 
original spectral curve without referring to spectra from model systems.  
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3. Results 
 
3.1. Binding studies 
 
 The reaction of preS domains with NBD-F led to the addition of the NBD 
moiety to the polypeptide chain. From the absorbance spectrum it can be 
calculated that approximately the protein was labeled in a 1:1 ratio. Taking into 
account that the reaction was carried out at pH 6.8, it is likely that the α-amino 
group, and not the Lys side chains, is the main labeling target. The NBD 
fluorophore has been employed in binding studies since its fluorescence spectrum 
reflects the environment in which the NBD group is located [17, 22]. Emission 
spectra of NBD-labeled preS proteins were recorded in buffer or upon interaction 
with PC or PG Small Unilamellar Vesicles (SUV). The wavelength of the 
maximum of the emission spectrum of labeled proteins under these conditions is 
shown in Table 1. In solution both proteins exhibited emission maxima centered 
at 544 nm, which is consistent with previously reported emission wavelength for 
NBD derivatives [23]. Upon interaction with negatively charged phospholipids, 
and under saturating conditions to avoid the contribution of the free protein to the 
emission spectrum, these maxima were shifted to 522 nm. The observed blue shift 
reflects a relocation of the NBD group in a more hydrophobic environment which 
is consistent with the insertion of the protein within the bilayer. In the presence of 
neutral phospholipids there is a small change in the position of the maximum 
(Table 1) which should reflect a more shallow location of the protein within the 
bilayer [17]. 
 In order to calculate the extent of binding, the labeled proteins, at a final 
concentration of 0.15 μM, were titrated with increasing amounts of PG or PC 
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vesicles. This protein concentration was low enough to avoid aggregation of 
vesicles. Moreover, control experiments were performed by titrating unlabeled 
proteins with the same concentration of vesicles. The measured increase in 
fluorescence at 530 nm, after subtracting the contribution of the control samples, 
was plotted against the phospholipid concentration (Fig. 1). After incubation with 
PGh, there is a significant increase in fluorescence intensity either at pH 7.0 or pH 
5.0 (Fig. 1), although the effect is higher at acidic pH. From these data binding 
isotherms were obtained (Fig. 1, inset) as described in Materials and methods. The 
partition coefficients, reflecting the binding constants, were calculated as the 
slopes of these lines (Table 1). The values of Kp* determined in the presence of 
acidic phospholipids at pH 5.0, 3x105 M-1, were similar to those described for 
labeled peptides which insert into phospholipid bilayers [17]. However, as 
expected from the fluorescence increments, the coefficients obtained at pH 7.0 
were two orders of magnitude lower. On the other hand, when neutral 
phospholipids were used in these experiments, no increase in F530 values were 
obtained at pH 7.0 (data not shown) and at pH 5.0 the calculated partition 
coefficients were similar to those observed with acidic phospholipids at neutral 
pH (Table 1). 
 
3.2. Fluorescence polarization 
 
 To ascertain the existence of a hydrophobic component in the interaction of 
the preS proteins with acidic and neutral phospholipids, their effect on the 
thermotropic behavior of DMPG and DMPC vesicles has been studied by 
measuring the fluorescence polarization of these liposomes labeled in the 
hydrophobic core of the bilayer with the fluorescent probe DPH. Fig. 2 shows the 
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fluorescence depolarization of DPH-labeled DMPG vesicles with increasing 
temperatures in the presence of preS-his proteins adw (A, B) or ayw (C, D) at 
different protein/phospholipid molar ratios at pH 7.0 (A, C) and 5.0 (B, D). The 
addition of preS-his proteins to DMPG vesicles induced a decrease in the 
amplitude of the transition in a concentration-dependent manner, without affecting 
the temperature of the transition. This effect was observed almost exclusively at 
temperatures above the transition temperature, indicating that the proteins affected 
mainly the acyl chains in the liquid-crystal phase, inducing a higher order in the 
chain packing. At low protein concentrations the effect was slightly higher at 
acidic pH. However, when protein concentration increased, the effects were 
nearly indistinguishable at both pHs. As observed in all the insets of Fig. 2, the 
fluorescence polarization measured at 37 ºC increased linearly up to a protein to 
lipid ratio of 0.045, remaining constant from this point. The fact that the 
amplitude of phase transition was mainly the only modified parameter reveals the 
importance of the hydrophobic component in the interaction of preS domains with 
phospholipids. On the other hand, no effects in the transition curve of DMPC 
vesicles were observed (data not shown). 
When studies were performed using the fluorescent probe TMA-DPH, the 
results obtained were very similar to those described above for DPH (data not 
shown).  
 
3.3. Vesicle aggregation 
 
 Vesicle aggregation was monitored by measuring the increment of the 
optical density at 360 nm (ΔOD360) of PGh liposomes as a result of the increase in 
vesicle size upon incubation with different concentrations of preS-his proteins. 
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Fig. 3 shows the results obtained with preS-his adw, being those with preS-his 
ayw very similar. The ΔOD360 value increased up to a protein concentration of 6-8 
μM and then remained constant. This effect was observed both at pH 7.0 and 5.0 
although ΔOD360 was slightly higher at acidic pH. On the other hand, when preS-
his were incubated with neutral phospholipids, the increase of OD360 at any pH 
value was almost negligible (data not shown). 
 Vesicle aggregation was also measured at different PG concentrations and 
maintaining a constant protein to lipid molar ratio of 1:75 (Fig. 3, inset). As it was 
expected, OD360 augmented almost linearly up to a lipid concentration of 1.5 mM 
and remained constant up to 2.0 mM. However, at 2.6 mM PG (34.6 μM of preS-
his adw) the optical density diminished to values even lower than the 
corresponding control, indicating a possible disruption of the vesicles. These 
results were similar both at pH 7.0 and 5.0 and using either preS-his-adw or preS-
his-ayw. 
 
3.4. Lipid mixing 
 
 Mixing of phospholipid vesicles was followed by the decrease in resonance 
energy transfer (RET) between the fluorescent probes NBD-PE and Rh-PE 
incorporated into a lipid matrix [20], which accurately reflects the degree of 
fusion [24]. As observed in Fig. 4 preS domains of both ayw (Fig. 4A) and adw 
(Fig. 4B) subtypes were able to induce lipid mixing when using PG vesicles, both 
at pH 7.0 and 5.0. Although at low protein concentration the decrease of RET was 
more pronounced at acidic pH, the results obtained at both pH values made equal 
as the protein concentration was increased. At either pH value %RET decreased 
from 72, in the absence of protein, to 18-20 at 10 μM preS-his. These values 
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correspond to a dilution in acceptor surface density of approximately eightfold, 
indicating that, under the conditions studied, the complete fusion of vesicles was 
produced, since their mere aggregation would not result in such a change in 
energy transfer [25]. 
  
3.5. Release of aqueous contents 
 
 The ability of preS proteins to destabilize the lipid bilayer was also assessed 
by determining the release of aqueous content of phospholipid vesicles. Liposome 
leakage was monitored by measuring the increase in ANTS fluorescence at 520 
nm [26]. Fig. 5 shows the leakage induced by ayw (Fig. 5A) and adw (Fig. 5B) 
preS-his domains when added to PG vesicles. Both proteins were able to induce 
the release of internal contents of the vesicles in a concentration-dependent 
manner. The maximum effect was attained at 0.5-1.0 μM of protein, concentration 
much lower than those needed to induce vesicle aggregation or lipid mixing (5-10 
μM). On the other hand, at low protein concentrations leakage was slightly higher 
at acidic pH, being the pH dependence of the lipid destabilization lower than that 
observed in the aggregation and lipid mixing assays. The maximum fluorescence 
reached with either protein, 75-85%, is similar to that described for other proteins 
and did not attain the value obtained when liposomes were lysed with the 
detergent Triton X-100 (100% leakage). 
 
3.6. Electron microscopy studies 
 
 Incubation of preS-his domains with PG liposomes had effects on the 
morphology and size of the phospholipid vesicles as can be observed by electron 
 18
microscopy after negative staining with sodium phosphotungstate. Fig. 6 shows 
the results obtained with PG vesicles in the presence of preS-his adw at pH 7.0. 
Fig. 6A indicates that control PG vesicles had a homogeneous size of 100-130 
nm. Addition of protein at a concentration of 5.3 μM induced aggregation and 
fusion of liposomes, leading to the disappearance of the original half moon typical 
staining of control PG vesicles that instead adopted large aggregated structures of 
250-420 nm (Fig. 6B). Furthermore, in some cases interaction with preS-his 
protein induced formation of filaments (Fig. 6C). When lipid and protein 
concentrations were increased, maintaining unchanged the molar ratio, the PG 
vesicles were fragmented into smaller, 30-60 nm, particles (Fig. 6D); this 
observation is in accordance with the aggregation studies (Fig. 3, inset), and 
indicates that the protein was able to induce the vesicle disruption under these 
conditions. 
 
3.7. Circular dichroism 
 
 The interaction and insertion of preS domains into the hydrophobic core of 
phospholipid vesicles brought about a conformational change which could be 
assessed by circular dichroism. Thus, Fig. 7 shows the CD spectra of adw preS-his 
at pH 7.0 (Fig. 7A) and 5.0 (Fig. 7B) both alone and in the presence of egg PG. At 
either pH, the CD spectrum of preS domains is characteristic of a protein with a 
high content of non-regular structure. However, in the presence of acidic 
phospholipids there is an increase in the ellipticity values together with a shift of 
the minimum from 200 to 205 nm and the appearance of a shoulder at 225 nm, 
characteristic of helical structure. In fact, deconvolution of CD spectrum by CCA 
method indicated that the percentage of helical content increased from 0 to 10% 
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with the concomitant decrease of non-regular structures. The results obtained with 
the ayw subtype were similar (data not shown). However, no changes in the CD 
spectrum were observed in the presence of neutral phospholipids. 
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4. Discussion 
 
 Based on a previously reported method which relies on the changes of the 
fluorescence properties of NBD-labeled peptides or proteins [17], it can be 
assessed that preS domains interact with phospholipid vesicles. The addition of 
increasing concentrations of phospholipids to NBD-labeled proteins led to a shift 
in the fluorescence emission maximum of NBD as well as to an increase in the 
fluorescence intensity at 530 nm. As described for other peptides, the first data 
gives information about the location of the protein in the bilayer after the 
interaction [17]. Thus, in the presence of acidic phospholipids the maximum was 
shifted to 520-522 nm, both at pH 7.0 and 5.0, indicating that the NBD was 
located in a more hydrophobic environment, similarly to what has been described 
for peptides deeply inserted into the bilayer (λmax=518-528 nm). However, in the 
presence of neutral phospholipids the position of the emission maximum 
(λmax=534 nm) was analogous to that observed for peptides interacting with the 
bilayer at the surface [17]. On the other hand, binding isotherms, derived from the 
increments in fluorescence intensities, provide information about the mechanism 
of the interaction [18, 27]. Thus, the straight lines obtained in all cases denoted 
that the proteins interact with the bilayer in a monomeric form, being unnecessary 
the formation of oligomers to elicit lipid-protein interactions. Furthermore, 
interaction coefficients were calculated from the slopes of the lines. Thus, in the 
presence of acidic phospholipids at pH 5.0 the values achieved with both preS 
domains were of the order of magnitude of those described for peptides having a 
strong interaction with the bilayer, such as the transmembrane peptides or even 
peptides forming pores in the membrane [17, 22, 28]. However, the constant 
reached at pH 7.0 was significantly lower, indicating a much lower interaction 
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between the protein and the phospholipids although NBD was located in a similar 
hydrophobic environment to that at pH 5.0. When neutral lipids were used, no 
binding at pH 7.0 was detected, being the increment in fluorescence intensities at 
pH 5.0 markedly lower, although the calculated partition coefficients were similar 
to those obtained with PG at pH 7.0. These strong differences observed with both 
types of phospholipids reveal the importance of electrostatic interactions in the 
binding of preS domains to lipid vesicles. 
  
 Fluorescence depolarization studies confirmed the above mentioned 
specificity. The observed decrease of the transition enthalpy together with the 
maintenance of the transition temperature are typical effects of integral membrane 
proteins [29], suggesting that preS domains are able to insert into the lipid bilayer 
as a consequence of their interaction with acidic phospholipids. Moreover, 
assuming that the NBD labeling was mainly produced in the α-amino group, the 
amino terminal region of preS domains should be the area inserted into the 
bilayer. When fluorescence depolarization was plotted against the protein to lipid 
ratio, a linear increase was obtained until a relationship of 0.045. This value 
would indicate that each molecule of protein prevented an average of 22 
phospholipid molecules to undergo a phase transition. The use of DPH, a 
fluorescent probe that gives information of the deep core regions of the bilayer 
[30], indicates that insertion is stabilized by hydrophobic interactions between the 
acyl chains and the protein. However, data from TMA-DPH fluorescence 
depolarization, a probe partitioning into surface regions of the bilayer [31], 
indicate that an electrostatic component must also be involved in the interaction. 
Thus, the insertion of preS domains into the bilayer would take place in two steps: 
a first one governed by electrostatic interaction between the phospholipid polar 
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head and the preS domain which is intrinsically basic, and a second step driven by 
hydrophobic interactions which leads to the insertion of the protein into the 
bilayer. When the first step does not take place, such as when neutral 
phospholipids are used, the protein does not insert into the bilayer. Moreover, this 
mechanism of interaction would explain the differences observed with acid 
phospholipids at pH 7.0 and 5.0. The increment in positive charge as the pH is 
diminished would favor the initial step and hence the insertion into the bilayer. It 
is worth noting that these differences cannot be attributed to a conformational 
change of the protein but rather to a modification in their ionic state since the 
spectroscopic properties at pH 5.0 are coincident with those previously described 
at pH 7.0 [16]. 
 
 As it comes about for other viral fusogenic proteins such as the influenza 
virus haemagglutinin [32] or the vesicular stomatitis virus haemagglutinin [33], 
preS domains were able to destabilize model membrane systems. Thus, the 
interaction with negatively charged vesicles induced their aggregation. However, 
these effects were not observed when neutral phospholipid vesicles were used, 
indicating that the weak interaction that takes place between the proteins and these 
type of lipids, assessed by the NBD-labeling studies, was not able to promote the 
vesicle-vesicle contacts necessary to form the aggregates. Moreover, in the case of 
acid phospholipids, lipid mixing studies indicate that the aggregation process lead 
to fusion. The maximum degree of aggregation and lipid mixing was attained at a 
protein concentration of 5-10 μM. However preS domains were able to disrupt the 
physical integrity of negatively charged phospholipid vesicles at a considerably 
lower concentration (1 μM), giving rise to the release of the aqueous contents. 
Electron microscopy studies revealed that the average size of vesicles increased 
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from 100-130 nm to 250-430 nm after their aggregation and fusion induced by 
preS domains. On the other hand, under the conditions at which OD360 diminished 
to values even lower than those obtained in the absence of protein, electron 
microscopy revealed a particle size of 30-60 nm, also lower than the size of 
control vesicles, indicating that preS domains have the ability to induce the 
fragmentation of previously fused liposomes. This effect has been also described 
for some other proteins, as the myelin basic protein [34], and for peptides, as the 
WHV fusogenic peptide [14]. The filaments observed in some fused vesicles 
could act as starting points for fragmentation. 
 
 The destabilization properties mentioned above show some pH dependence. 
At low protein concentrations these membrane perturbing properties increased as 
the pH was decreased, revealing, once again, the importance of the electrostatic 
interaction between the protein and the phospholipid polar head group. This 
dependence would support the hypothesis that fusion of HBV with the hepatocyte 
should take place in acidic vesicles, just after a receptor-mediated endocytosis 
process. However, the fact that destabilization was produced at both pHs and that 
the observed differences were mostly canceled at higher protein concentrations, 
would be in accordance with a pH-independent viral infection model, since in 
cases of viruses infecting cells in a pH-dependent manner no destabilizing effect 
at neutral pH should be observed at all. The physiological significance of the 
increase in the fusogenic properties at acidic pH is not clear, but it has been also 
observed in other viruses entering the cell by fusion with its plasmatic membrane 
at neutral pH, as it is the HIV [35]. On the other hand, studies performed with the 
glycoprotein HA of the pH-dependent influenza virus demonstrated that, in the 
presence of liposomes, the decrease of pH promoted a conformational change in 
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the protein consisting in the exposure of the fusogenic peptide that results in the 
binding of the protein to the vesicles; however, if this protein was incubated at 
acidic pH in the absence of membranes, an irreversible conformational change 
was produced, resulting in a drastic binding decrease [36]. The results obtained 
herein with preS domains were unchanged no matter the pH was adjusted just 
before or after the addition of the phospholipid vesicles. Thus, these results might 
indicate that entry of hepatitis B virus into hepatocytes would be pH-independent.  
 
 On the other hand, interaction with liposomes also involves structural 
alterations in the preS domains. CD spectra in the presence of acidic phospholipid 
vesicles are indicative of a conformational change as a consequence of the 
interaction which increased the helical content of the protein. Although CCA 
method is based on globular proteins and hence the results obtained with protein-
lipid systems can not be taken as absolutely precise, the change in the shape of the 
spectra is enough to infer such a conformational change. The increase on helical 
content gives no clue on the viral fusion mechanism since both α-helix and β-
sheet have been shown to take part in the fusion steps of other viruses [37, 38]. 
 
 In summary, the results reported in this work demonstrate that HBV preS 
domains display membrane perturbing properties similar to those described for the 
N-terminal S peptide [11]. Furthermore, the interaction properties should be 
adscribed to the polypeptide chain and not to the His tag since a purified preS 
domain which does not contain the tag possesses similar destabilizing properties. 
It has been postulated that the mechanism by which fusion proteins facilitate the 
formation of fusion intermediates is a complex process involving several 
membranotropic segments [39]. Moreover, the involvement of different regions of 
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a protein on the membrane fusion process has indeed been proposed for various 
enveloped virus harboring additional membrane fusion motifs [40], and more 
recently, for the Hepatitis C virus [41, 42]. Hence, in the case of HBV, it could be 
possible that different segments of the surface proteins, located in preS domains 
and in the N-terminal portion of the S polypeptide, might contribute to membrane 
fusion acting either simultaneously or at different stages.  
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Tables 
Table 1  
Fluorescence emission maxima of NBD-labeled preS domains in solution or in the 
presence of PC and PG vesicles and corrected partition coefficients (Kp*) 
determined from the initial slopes of the binding isotherms, as indicated in the 
Materials and methods section. 
 
 Emission Maxima Kp* (M-1) x 10-5
 
 pH 
Buffer PGh PCh PGh PCh
7.0 544 522 534 0.1 - 
 
NBD-preS-
his-ayw 5.0 544 522 534 2.9 0.11 
7.0 544 522 534 0.047 - NBD-preS-
his-adw 5.0 544 520 534 3.0 0.036 
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LEGENDS 
 
Fig 1. Increase in fluorescence of NBD-preS-his proteins upon titration with PGh 
vesicles. Labeled preS-his-ayw (●) and preS-his-adw (○) proteins (0.15 μM) were 
added to PGh vesicles at different lipid concentrations in medium buffer at pH 5.0 
(A) or 7.0 (B). The mixtures were incubated at 37 °C for 2 min and fluorescence 
intensity was measured at 530 nm. Insets represent the binding isotherms 
obtained from the increments of NBD fluorescence intensities. Values of Xb* and 
Cf were calculated as indicated under Materials and methods. The results shown 
are representative of those obtained for three different experiments. 
  
Fig. 2. Temperature dependence of the fluorescence polarization of DPH-labelled 
DMPG liposomes. Vesicles were incubated with different concentrations of preS-
his-adw (A, B) or preS-his-ayw (C, D) proteins for 30 min at 37 °C in medium 
buffer at pH 7.0 (A, C) or 5.0 (B, D). After cooling, polarization was measured at 
the indicated temperature. The phospholipid concentration was 0.14 mM and the 
preS/lipid molar ratios employed were (▲) 0.0, (●) 0.01 and (■) 0.045. Insets 
represent fluorescence polarization at 37 °C as a function of protein/phospholipid 
ratio. The results shown are representative of those obtained for three different 
experiments. 
 
Fig. 3. Aggregation of egg PG phospholipids vesicles induced by preS-his-adw 
protein. The optical density at 360 nm (ΔOD360) was measured after incubation of 
vesicles (0.14 mM) in medium buffer at pH 7.0 (○) and 5.0 (●) with proteins at 
different concentrations. Values of control samples containing only PG liposomes 
were subtracted. Inset represents the ΔOD360 as a function of PG concentration at 
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a constant protein/lipid ratio of 1:75 at pH 7.0. The results shown are 
representative of those obtained for at least three different experiments. 
 
Fig. 4. Lipid mixing induced by preS proteins. Increasing concentrations of preS-
his-ayw (A) or preS-his-adw (B) were added to a 1:9 mixture of labelled (NBD-
PE 1% and Rh-PE 1%) and unlabeled PG vesicles hydrated in medium buffer at 
pH 7.0 (○) and 5.0 (●). The Resonance Energy Transfer (RET) between NBD-PE 
and Rh-PE was calculated as indicated in Materials and methods. The results 
shown are representative of those obtained for three different experiments. 
 
Fig. 5. Leakage of ANTS/DPX from egg PG vesicles induced by preS proteins. 
Increasing concentrations of preS-his-ayw (A) or preS-his-adw (B)  were added to 
vesicles loaded with ANTS and DPX in medium buffer at pH 7.0 (○) and 5.0 (●). 
The mixtures were incubated at 37 °C for 1 h and the fluorescence intensity was 
measured at 520 nm. Maxima fluorescence was obtained upon addition of 0.5% 
Triton X-100. The results shown are representative of those obtained for at least 
three different experiments. 
 
Fig. 6. Electron micrographs of egg PG vesicles in the presence of preS-his-adw 
protein. PG liposomes were incubated with the protein at pH 7.0 for 1 h at 37 °C 
and the mixtures were transferred to glow-discharged Formvar-carbon-coated 
grids. Afterwards, they were negatively stained with sodium phosphotungstate. 
(A) egg PG vesicles (0.14 mM) in the absence of protein. (B-D) PG-preS mixtures 
at a 1:75 molar lipid/protein ratio; (B,C) [PG]=0.4 mM; (D) [PG]=2.65 mM. The 
bar indicates 150 nm.  
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Fig. 7. CD spectra of preS-his-adw protein incubated for 1 h at 37 °C with egg PG 
vesicles. The circular dichroism spectra were recorded both in the absence (▲) 
and the presence (●) of egg PG liposomes, at pH 7.0 (A) and 5.0 (B). The protein 
concentration was 0.1 mg/ml, and the lipid/protein molar ratio was kept at 20:1. 
 
 
 





 
 
 
 
 
 
 
 
 

